Rafael Hofstein


Dr. Hofstein has served on our Board of Directors since 2003, our Audit Committee since 2007, and our Compensation Committee since 2012. Dr. Hofstein served as the President and Chief Executive Officer of MaRS Innovation (a commercialization company for 15 of Toronto’s universities, institutions, and research institutes, plus the MaRS Discovery District) from June 2009 to March 2020. From 2000 through June 2009, Dr. Hofstein was the President and Chief Executive Officer of Hadasit Medical Research Services and Development Ltd. (or Hadasit), the technology transfer company of Hadassah University Hospitals. He has served as Chairman of the Board of Directors of Hadasit since 2006. Prior to joining Hadasit, Dr. Hofstein was the President of Mindsense Biosystems Ltd. and the Business Unit Director of Ecogen Inc. and has held a variety of other positions, including Manager of R&D and Chief of Immunochemistry at the International Genetic Science Partnership. Dr. Hofstein serves on the Board of Directors of numerous companies. Dr. Hofstein received his PhD and MSc from the Weizmann Institute of Science and his BSc in chemistry and physics from the Hebrew University in Jerusalem. Dr. Hofstein completed postdoctoral training at Harvard Medical School in both the departments of biological chemistry and neurobiology.